RIFAXIMIN 200 MG TABLET (PC.00217.2026)
About This Opportunity
TranslatedThis tender pertains to the procurement of Rifaximin 200 mg tablets, identified by the reference number PC.00217.2026. Rifaximin is an antibiotic used primarily for the treatment of gastrointestinal infections, particularly those caused by non-invasive strains of Escherichia coli. The tender is likely aimed at healthcare providers or pharmaceutical distributors who can supply this medication in the specified dosage form. Key requirements may include compliance with regulatory standards for pharmaceutical products, quality assurance certifications, and the ability to meet delivery timelines. The location for the delivery of these tablets has not been specified in the provided information, but it is essential for bidders to indicate their capacity to fulfill the order within the required geographical area. Additionally, bidders may need to provide evidence of previous experience in supplying similar pharmaceutical products to public health institutions or government agencies. This tender represents an opportunity for suppliers in the pharmaceutical sector to contribute to public health initiatives by ensuring the availability of essential medications.
This is a supplies contract in the health and medical services and trade and industry sectors, with a focus on Pharmaceuticals, Manufacturing and Quality Standards. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 2,427.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThis tender pertains to the procurement of Rifaximina 200 mg tablets, referenced as PC.00217.2026, and is issued within the public contracting framework of Portugal. The pharmaceutical product Rifaximina is an antibiotic commonly utilized for the treatment of gastrointestinal infections, particularly those caused by certain bacteria, and is essential in managing conditions such as traveler's diarrhea and hepatic encephalopathy.
The contracting authority overseeing this procurement is likely to be a public health institution or a government agency responsible for healthcare supply within Portugal. The tender aims to secure a reliable supply of Rifaximina 200 mg formulations to ensure continuous availability for healthcare providers and patients across the country.
Typical requirements for this type of tender may include compliance with Portuguese and European Union pharmaceutical regulations, evidence of Good Manufacturing Practices (GMP) certification, and the provision of detailed product specifications. Bidders may also be required to demonstrate their capacity for timely delivery, adherence to quality assurance standards, and the capability to provide post-sales support.
Interested suppliers should prepare detailed proposals that include pricing, delivery schedules, and information on product sourcing. The tender process emphasizes transparency and competition, ensuring that the best value for public funds is achieved while maintaining high standards of patient care. Registration on the BASE portal is essential for participating vendors to access further details and submit their bids for consideration.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 20, 2026. Last refreshed 4 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde de Viseu Dão-Lafões, EPE
Unidade Local de Saúde de Viseu Dão-Lafões, EPE has issued 600 procurement notices on BidsFactory, including 12 currently open and 543 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde de Viseu Dão-Lafões, EPE in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €2,427. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to Alfasigma Portugal, Lda.. The award notice is archived on BidsFactory for transparency and market intelligence.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.